V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210002776 | 210008565 | 1.58 | 106.6 | Adjuvant (A) | 2018-12-01 | 2018-12-16 | Docetaxel | null | N | DOCETAXEL | 100690882 |
| 210002777 | 210008566 | null | 79.1 | null | null | 2020-04-20 | Docetaxel | null | null | DOCETAXEL | 100476756 |
| 210002779 | 210008567 | 1.54 | 92.6 | Adjuvant (A) | null | 2020-04-26 | PACLITAXEL | null | null | PACLITAXEL | 100559144 |
| 210002781 | 210008568 | 1.62 | 79 | Palliative (P) | 2019-12-06 | 2019-12-20 | Docetaxel 100mg/m2 (21 day) | 02 | N | DOCETAXEL | 100515355 |
| 210002783 | 210008570 | 1.79 | 47.5 | Neo-adjuvant (N) | null | 2017-02-08 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | PACLITAXEL | 101475663 |
| 210002784 | 210008571 | 1.66 | 72.2 | Adjuvant (A) | 2018-08-16 | 2018-11-01 | Docetaxel | 02 | N | DOCETAXEL | 101651624 |
| 210002785 | 210008572 | null | 96 | null | 2017-09-20 | 2017-09-26 | EC | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101711722 |
| 210002787 | 210008574 | 1.65 | 48 | null | null | 2018-09-06 | TRASTUZUMAB | null | null | TRASTUZUMAB | 100511243 |
| 210002789 | 210008576 | 1.56 | 68 | null | 2018-01-12 | 2018-03-19 | Paclitaxel 7 day | 02 | null | PACLITAXEL | 100284199 |
| 210002790 | 210008577 | 1.64 | null | Palliative (P) | 2021-08-10 | 2021-10-21 | Trastuzumab Subcutaneous | null | N | TRASTUZUMAB | 101296586 |
| 210002791 | 210008578 | 1.6 | 88.9 | Adjuvant (A) | 2016-05-18 | 2016-07-21 | Trastuzumab Subcutaneous | N | N | TRASTUZUMAB | 100848575 |
| 210002794 | 210008580 | 1.58 | 61.1 | Adjuvant (A) | 2021-04-13 | 2021-04-19 | Docetaxel 75mg/m2 (21 day) | null | null | DOCETAXEL | 100726234 |
| 210002796 | 210008582 | 1.58 | 70.9 | null | 2015-11-28 | 2016-07-13 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100652125 |
| 210002797 | 210008583 | 1.58 | 65.1 | Adjuvant (A) | null | 2018-06-03 | PACLITAXEL | 02 | N | PACLITAXEL | 100731070 |
| 210002798 | 210008584 | 1.56 | 52.8 | Adjuvant (A) | null | 2019-04-04 | Trastuzumab | 02 | N | TRASTUZUMAB | 101664851 |
| 210002799 | 210008585 | 1.6 | 82.5 | Adjuvant (A) | null | 2019-02-23 | TRASTUZUMAB | 02 | N | TRASTUZUMAB | 100215459 |
| 210002800 | 210008586 | 1.52 | 51.9 | null | 2018-11-01 | 2018-11-01 | Docetaxel | null | null | DOCETAXEL | 101314266 |
| 210002801 | 210008587 | null | null | Palliative (P) | 2020-09-28 | 2020-12-15 | EC | N | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101390908 |
| 210002802 | 210008588 | 1.56 | 115 | Adjuvant (A) | 2016-10-07 | 2016-10-26 | Trastuzumab | 02 | N | TRASTUZUMAB | 100054339 |
| 210002803 | 210008589 | 1.59 | 59.4 | null | 2019-08-20 | 2019-10-30 | EC | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100331790 |
| 210002804 | 210008590 | 1.58 | 85.8 | Neo-adjuvant (N) | 2016-12-08 | 2017-01-07 | Docetaxel 100mg/m2 (21 day) | null | N | DOCETAXEL | 100294758 |
| 210002805 | 210008591 | 1.59 | 60.7 | Adjuvant (A) | null | 2020-05-19 | EC | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101615942 |
| 210002806 | 210008592 | 1.77 | 72.7 | Curative (C) | 2018-07-25 | 2018-08-09 | EC | N | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101280102 |
| 210002808 | 210008593 | 0 | null | Neo-adjuvant (N) | null | 2018-10-08 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100176034 |
| 210002811 | 210008594 | null | 66.1 | null | 2018-12-03 | 2019-02-15 | EC | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101738903 |
| 210002813 | 210008596 | 1.62 | 91 | Adjuvant (A) | 2018-03-03 | 2018-06-28 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100931928 |
| 210002815 | 210008597 | 1.72 | 55 | null | 2019-01-24 | 2019-01-24 | EC | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100882474 |
| 210002816 | 210008598 | 1.75 | 59.4 | null | 2019-01-11 | 2019-02-17 | EC | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101568694 |
| 210002817 | 210008599 | 1.62 | 77.6 | Neo-adjuvant (N) | null | 2018-10-01 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | PACLITAXEL | 101160914 |
| 210002819 | 210008601 | 1.65 | 69 | null | 2019-03-28 | 2019-06-08 | EC | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100297554 |
| 210002820 | 210008602 | 1.59 | 61.25 | null | null | 2018-08-06 | Docetaxel 100mg/m2 (21 day) | 02 | N | DOCETAXEL | 100906082 |
| 210002822 | 210008604 | 1.57 | 53.7 | Adjuvant (A) | 2017-04-06 | 2017-06-23 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 100138316 |
| 210002825 | 210008605 | 1.56 | 89 | null | 2019-04-17 | 2019-06-30 | TRASTUZUMAB | null | N | TRASTUZUMAB | 101483217 |
| 210002826 | 210008606 | 1.62 | 0 | Adjuvant (A) | 2019-03-25 | 2019-07-10 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100004928 |
| 210002827 | 210008607 | 1.64 | 72 | Adjuvant (A) | null | 2021-11-22 | TRASTUZUMAB | N | N | TRASTUZUMAB | 100992096 |
| 210002828 | 210008608 | null | null | null | 2017-06-27 | 2017-07-08 | Trastuzumab | null | null | TRASTUZUMAB | 101782261 |
| 210002829 | 210008609 | 1.75 | 67.4 | null | 2018-07-31 | 2018-08-20 | Trastuzumab | 02 | null | TRASTUZUMAB | 100488306 |
| 210002830 | 210008610 | 1.74 | 56 | Curative (C) | 2017-10-04 | 2017-10-27 | Trastuzumab Subcutaneous | 2 | N | TRASTUZUMAB | 100861905 |
| 210002834 | 210008611 | 1.6 | 95 | Palliative (P) | 2017-10-31 | 2017-10-31 | Docetaxel 100mg/m2 (21 day) | null | N | DOCETAXEL | 100315634 |
| 210002835 | 210008612 | null | 83.9 | Adjuvant (A) | 2020-03-05 | 2020-03-05 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100308047 |
| 210002836 | 210008613 | 1.63 | 90.7 | Adjuvant (A) | 2017-05-14 | 2017-09-18 | Docetaxel 100mg/m2 (21 day) | 02 | N | DOCETAXEL | 100919568 |
| 210002837 | 210008614 | 1.61 | 54.1 | Adjuvant (A) | 2019-09-16 | 2019-10-05 | Trastuzumab Subcutaneous | N | N | TRASTUZUMAB | 100468296 |
| 210002838 | 210008615 | 1.62 | 90.7 | Neo-adjuvant (N) | null | 2017-07-14 | Docetaxel 100mg/m2 (21 day) | null | N | DOCETAXEL | 101752604 |
| 210002839 | 210008616 | null | null | null | null | 2019-03-04 | Trastuzumab Subcutaneous | N | null | TRASTUZUMAB | 100661655 |
| 210002840 | 210008617 | 1.71 | 68.2 | Neo-adjuvant (N) | 2016-06-25 | 2016-07-30 | Trastuzumab | null | null | TRASTUZUMAB | 101817323 |
| 210002841 | 210008618 | 1.67 | 92 | Palliative (P) | 2017-05-26 | 2017-08-27 | Docetaxel | 02 | null | DOCETAXEL | 101101620 |
| 210002843 | 210008620 | 1.63 | 48.2 | Adjuvant (A) | 2019-10-11 | 2020-01-04 | Docetaxel | 02 | N | DOCETAXEL | 101788009 |
| 210002844 | 210008621 | 1.56 | 114 | Palliative (P) | 2017-10-22 | 2018-01-01 | Docetaxel | null | null | DOCETAXEL | 101044268 |
| 210002850 | 210008623 | null | 108.9 | null | 2017-10-30 | 2017-11-11 | Docetaxel 100mg/m2 (21 day) | N | N | DOCETAXEL | 100707337 |
| 210002851 | 210008624 | null | 69 | Adjuvant (A) | 2018-08-21 | 2018-08-23 | Docetaxel 100mg/m2 (21 day) | N | N | DOCETAXEL | 100371474 |